News items Major European grant for research into hypos
23 February 2018

A European consortium led by Radboud university medical center has been awarded a European grant worth € 26 million for research into hypoglycemia. To curb the health risks and burden of disease caused by the ‘hypo’ (as it is known), in-depth research will be carried out by knowledge institutions, patient organizations and partners from industry.

Diabetes is the most common chronic disease in the world. Europe alone has around 60 million patients, 10% of whom have type 1 diabetes. People with diabetes are unable to regulate the level of glucose in their blood automatically and use insulin to reduce high glucose (or sugar) levels. This is a very precise process. One of the side-effects of using insulin is developing a low concentration of glucose in the blood. This is known as hypoglycemia, or ‘hypo’ for short. 

Important obstacle

Hypoglycemia is a serious side-effect that can cause symptoms such as confusion, cognitive problems and loss of consciousness. For this reason, patients and their families dread ‘hypos’. Hypoglycemia not only affects the patient’s quality of life, it also increases the risk of cardiovascular disease. Hypoglycemia is therefore an important obstacle when it comes to effective treatment for diabetes. 

European grant

The Hypo-RESOLVE consortium, headed by doctors of internal medicine Bastiaan de Galan and Cees Tack, theme Mitochrondrial diseases, was recently awarded a grant worth € 26 million by the European Commission. The funding is for research designed to reduce the disease burden and consequences of hypoglycemia. The research project Hypo-RESOLVE (Hypoglycemia – Redefining SOLutions for better liVEs) was allocated a grant within the framework of the EU Horizon 2020-IMI program. 

Understanding the hypo

Bastiaan de Galan: “We want to formulate the answers to questions that still go unanswered almost one hundred years after the discovery of insulin. One of our methods will be to set up a mega-database in which we combine 100 to 150 insulin trials to ascertain exactly how often hypoglycemia occurs. This will help us to define hypoglycemia and identify predictors in various populations. We can then use this information to derive practical standards and recommendations for pharmaceutical authorities, patient organizations and future research among patients.” 

Better treatment

Cees Tack: “We also intend to carry out fundamental and applied research to study and clarify the underlying mechanisms involved in hypoglycemia. This knowledge will enable us to develop new treatments for patients who don’t feel the warning signs of impending hypoglycemia. In addition, we will try to discover whether continuous glucose monitoring using a glucose sensor is worthwhile in practice. You mustn’t underestimate the psychological and economic impact of hypoglycemia on patients and their families. We want to define the extent of this impact as objectively as possible.”
The consortium hopes that this broad-based approach will ultimately achieve better quality of life for patients with diabetes who are treated with insulin.

More information


Pieter Lomans

information officer

(024) 81 87012

Related news items


Biomarkers found in COVID-19 patients support bradykinin hypothesis

29 May 2020

A study into inflammatory substances in the blood of COVID-19 patients supports the hypothesis that kinins could play a role in the respiratory problems experienced by critically ill COVID-19 patients in IC. This discovery, published at MedRxiv, could lead to the development of new treatments.

read more

Introducing OnePlanet Research Center webinar 5 June, 16:00 hrs.

29 May 2020

OnePlanet Research Center develops digital technologies to create a society in which everyone can live a healthy life and has access to healthy and sustainable food. Radboudumc and Radboud University are amongst the founding partners. Find out what OnePlanet can do for you in this online session.

read more

The impact of sex and gender in the COVID-19 pandemic

29 May 2020

The case study of Sabine Oertelt-Prigione, developed by the European Commission’s H2020 Expert Group to update and expand "Gendered Innovations/Innovation through Gender", examines the impact of sex and gender in the current COVID-19 pandemic.

read more

Terrestrial bacteria can grow on nutrients from space

26 May 2020

Researchers from the Radboudumc describe in an article in Astrobiology that bacteria can survive on an 'extraterrestrial diet', which affected their pathogenic potential.

read more

The new front line: big data podcast

22 May 2020

What role do big data and technology play in the fight against corona? What data can help save lives? How do you ensure that your personal health data is used safely? Among others, Peter-Bram 't Hoen explains.

read more

OARSI Basic Science Award for Peter van der Kraan

22 May 2020

Purpose of this Basic Science Award of the Osteoarthritis Research Society International (OARSI) is to stimulate fundamental research in the field of osteoarthritis. Congratulations Peter.

read more